In the interest of consistency and coherent efforts in preventing the entry of the African Swine Fever Virus, the Food and Drug Administration (FDA) hereby expands the temporary ban on the importation, distribution and sale of ALL processed pork meat products from the following countries following Department of Agriculture Memorandum Order No. 24 Series of 2019 and No. 20 Series of 2021:
(The FDA earlier issued FDA Order 2018-133 dated 24 September 2018, FDA Order No. 2019-045 dated 27 May 2019, FDA Order No. 2019-103 dated 30 July 2019, and FDA Order No. 2020-1283 dated 07 October 2020 on the temporary ban of pork meat and identifying the following countries infected with the African swine fever (ASF) virus, in line with the issued Memorandum Orders of the Department of Agriculture:)
- South Africa
- North Korea
- South Korea
The public is advised to exercise extreme caution in purchasing and consuming processed pork meat products and is advised to only consume processed pork meat products which are sourced from countries other than the above listed countries suspected to be affected by ASF virus, and are registered with the FDA.
Further, the FDA would like to reiterate that it does not allow the registration of processed pork meat products from these ASF virus affected countries. A heightened post-marketing surveillance and audit is being conducted on all concerned and covered establishments, to ensure full compliance to the foregoing FDA Orders, and at the same time, to hold violators liable under Republic Act 9711 (Food and Drug Administration Act of 2009), Republic Act 10611 (Food Safety Act of 2013) and other pertinent laws, rules and regulations, all in the interest of protecting public health and safety.
For more information and inquiries, please e-mail us at [email protected]ph or call us at FDA Action Center hotline (02) 821-1162, or the Center for Food Regulation & Research at (02) 857-1900 local 8112/8105. To report the sale or distribution of these banned products despite the issuance of FDA Orders, kindly email us via [email protected].
Dissemination of the information to all concerned is requested.